Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
01/1997
01/16/1997CA2225691A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof
01/16/1997CA2225405A1 Omp26 antigen from haemophilus influenzae
01/16/1997CA2224701A1 Bax omega protein and methods
01/16/1997CA2224662A1 Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3
01/16/1997CA2222849A1 Sequences for production of 2,4-diacetylphloroglucinol and methods
01/16/1997CA2222456A1 Vaccines against hepatitis c
01/16/1997CA2221294A1 Tetradotoxin insensitive sodium channel
01/16/1997CA2197861A1 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides
01/15/1997EP0753581A1 Improved recombinant eukaryotic cytoplasmic viruses, method for their production and their use as vaccines
01/15/1997EP0753578A1 Novel Bacillus thuringiensis isolate active against lepidopteran pests, and gene encoding novel lepidopteran-active toxin
01/15/1997EP0753577A1 Cell-surface polypeptide gene
01/15/1997EP0753574A1 Methods and compositions for obtaining ex vivo human progenitor cell expansion
01/15/1997EP0753528A1 Prostaglandin i 2? receptor
01/15/1997EP0753527A1 Prostaglandin e receptor
01/15/1997EP0753312A1 Arteriosclerosis remedy
01/15/1997EP0753310A1 Legionellosis vaccines and methods for their production
01/15/1997EP0753307A2 Human growth hormone agent for adults
01/15/1997EP0753304A1 Thrombolytic enzyme and method of obtaining same
01/15/1997EP0753152A1 Solid phase immunoassay to detect inhibitors of proteolytic enzymes
01/15/1997EP0753073A1 Heat-inducible n-degron module
01/15/1997EP0753071A1 Cell-targeted lytic pore-forming agents
01/15/1997EP0753069A1 Gene delivery fusion proteins
01/15/1997EP0753068A1 Ligands added to adenovirus fiber
01/15/1997EP0753067A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF)
01/15/1997EP0753066A1 Recombinant bcg vaccines
01/15/1997EP0753064A1 Method for the permanent expression of glutamate receptors
01/15/1997EP0753061A1 Vaccine compositions
01/15/1997EP0753060A1 Conserved t-cell receptor sequences
01/15/1997EP0753059A1 Peptide production as fusion protein in transgenic mammal milk
01/15/1997EP0753054A1 Expansins, proteins that catalyze plant cell wall expansion and weakening of paper fiber connections
01/15/1997EP0753015A1 Monoclonal antibodies recognizing tie-receptor and their use
01/15/1997EP0753014A1 IgM-SPECIFIC RECOMBINANT RHEUMATOID ARTHRITIS ANTIGEN
01/15/1997EP0753013A1 Neurotrophin-6: a new member of the neurotrophin family
01/15/1997EP0753012A1 A new 78 residue polypeptide (nk-lysine) and its use
01/15/1997EP0753011A1 Thymidine kinase tk1, peptide, corresponding antibodies and use of these in determination of tumor proliferation
01/15/1997EP0753010A1 A novel expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins
01/15/1997EP0753009A1 Malaria peptides
01/15/1997EP0753008A1 Peptide vaccines and methods relating thereto
01/15/1997EP0753006A1 Vpr AND Vpx PROTEINS OF HIV
01/15/1997EP0753005A1 Cytotoxic t-cell lymphocyte ("ctl") activity regulation by class i mhc peptides
01/15/1997EP0752888A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR
01/15/1997EP0752887A1 Immunodeficiency recombinant poxvirus
01/15/1997EP0752886A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
01/15/1997EP0752884A1 Method of treating auto-immune diseases using type one interferons
01/15/1997EP0752883A1 Use of mcp-1 for inducing ripening of the cervix
01/15/1997EP0752881A1 A novel brain endothelial cell protein and methods for its use
01/15/1997EP0752880A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
01/15/1997EP0752879A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES
01/15/1997EP0752878A1 Products comprising substrates capable of enzymatic cross-linking
01/15/1997EP0752876A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides
01/15/1997EP0752875A1 Glioblastoma-derived angiogenesis inhibiting factor
01/15/1997EP0752874A1 Enhanced virus-mediated dna transfer
01/15/1997EP0752853A1 Human brain phosphodiesterase
01/15/1997EP0752844A1 Human osteoclast-derived cathepsin
01/15/1997EP0752816A1 Nematicidal proteins
01/15/1997EP0736106A4 Methods of screening for beta-amyloid peptide production inhibitors
01/15/1997EP0671938A4 Novel biologically active peptides and uses therefor.
01/15/1997EP0593757B1 Method for obtaining polypeptides in a cell-free system
01/15/1997EP0527753B1 Purification and use of pertactin, a bordetella pertussis outer membrane protein
01/15/1997EP0491930B1 Primate lentivirus vaccines
01/15/1997CN1140456A Superagonists and antagonists of H IL-6, and 3-D modelling method for their selection
01/15/1997CN1140415A Treatment of antibiotic associated diarrhea
01/15/1997CN1033810C Process for enzymatic preparation of basic fibroblast growth factor
01/15/1997CA2160038A1 Methods of screening compounds for their pharmacological relevance based on downregulation of recombinant receptors
01/14/1997US5594123 Oligonucleotide primers which hybridize with conserved regions of the nucleic acid sequences of the aids virus, for polymerase chain reactions
01/14/1997US5594120 Integrin alpha subunit
01/14/1997US5594115 Fusion protein containing polypeptides and metal chelating peptide
01/14/1997US5594114 Schwann cell mitogenic factor, its preparation and use
01/14/1997US5594113 Isolated from horseshoe crabs; treating septic shock
01/14/1997US5594112 Acridinium compounds and conjugates thereof
01/14/1997US5594108 Schizophrenia
01/14/1997US5594107 Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon
01/14/1997US5594105 Peptide inhibitors of mitogenesis and motogenesis
01/14/1997US5594104 Anti-obesity proteins
01/14/1997US5594103 Lantibiotics similar to nisin a
01/14/1997US5594102 Hydrolysis to form antibiotics
01/14/1997US5594101 Anti-obesity proteins
01/14/1997US5594100 Epitope for prevention of type I diabetes
01/14/1997US5593972 Genetic immunization
01/14/1997US5593967 Cholecystokinin antagonists, their preparation and therapeutic use
01/14/1997US5593966 Peptide derivatives of cytochrome b558 and their use as medicaments
01/14/1997US5593962 Treating calcium deficiency
01/14/1997US5593959 Anticoagulants
01/14/1997US5593900 Immunological methods for the detection of the human type IV collagen α5 chain
01/14/1997US5593896 Competitive immunoassay
01/14/1997US5593884 Oncoprotein protein kinase
01/14/1997US5593882 Selectin variants
01/14/1997US5593881 Bacillus thuringiensis delta-endotoxin
01/14/1997US5593879 Cell death genes of Drosophila melanogaster and vertebrate analogs
01/14/1997US5593877 Nucleic acid and recombinant production of vespid venom hyaluronidase
01/14/1997US5593876 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality
01/14/1997US5593874 Dna for transgenic monocot plants and dna sequences
01/14/1997US5593873 Vaccines
01/14/1997US5593866 Cationic peptides and method for production
01/14/1997US5593865 Process for the activating of gene-technologically produced, heterologous, disulphide bridge-containing eukaryotic proteins after expression in prokaryotes
01/14/1997US5593864 Process for functional expression of the para cation channel
01/14/1997US5593863 Administration of an RNA stem loop structure to modulate protein synthesis
01/14/1997US5593862 Nucleic acids encoding drosophila tipE cation channel proteins and recombinant expression of the same
01/14/1997US5593860 Expression plasmids containing the deo promoter, and bacterial hosts containing the plasmids
01/14/1997US5593859 Gene codes and polypeptides for cells